Drug Shortage Report for SOLYSTAT

Last updated on 2018-02-05 History
Report ID 26779
Drug Identification Number 00769541
Brand name SOLYSTAT
Common or Proper name SOLYSTAT 250mg/mL SUSP 500mL
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) SODIUM POLYSTYRENE SULFONATE
Strength(s) 250MG
Dosage form(s) SUSPENSION
Route of administration ORAL
Packaging size 500ML
ATC code V03AE
ATC description ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-12-01
Actual start date 2017-12-01
Estimated end date 2018-02-07
Actual end date 2018-02-02
Shortage status Resolved
Updated date 2018-02-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2018-02-05 French Compare
v19 2018-02-05 English Compare
v18 2017-12-22 French Compare
v17 2017-12-22 English Compare
v16 2017-12-04 French Compare
v15 2017-12-04 English Compare
v14 2017-12-04 French Compare
v13 2017-12-04 English Compare
v12 2017-12-02 English Compare
v11 2017-11-27 French Compare
v10 2017-11-27 English Compare
v9 2017-11-20 French Compare
v8 2017-11-20 English Compare
v7 2017-11-18 English Compare
v6 2017-11-16 French Compare
v5 2017-11-16 English Compare
v4 2017-10-31 French Compare
v3 2017-10-31 English Compare
v2 2017-10-23 French Compare
v1 2017-10-23 English Compare

Showing 1 to 20 of 20